Dupuis-Girod S - Search Results

1

Executive summary of the 12th HHT international scientific conference.

Andrejecsk JW, Hosman AE, Botella LM, Shovlin CL, Arthur HM, Dupuis-Girod S, Buscarini E, Hughes CCW, Lebrin F, Mummery CL, Post MC, Mager JJ. Andrejecsk JW, et al. Angiogenesis. 2018 Feb;21(1):169-181. doi: 10.1007/s10456-017-9585-2. Angiogenesis. 2018. PMID: 29147802 Free article.

2

Primary Non-Aortic Lesions Are Not Rare in Marfan Syndrome and Are Associated with Aortic Dissection Independently of Age.

Sénémaud J, Gaudry M, Jouve E, Blanchard A, Milleron O, Dulac Y, Olivier-Faivre L, Stephan D, Odent S, Lanéelle D, Dupuis-Girod S, Jondeau G, Bal-Theoleyre L. Sénémaud J, et al. J Clin Med. 2023 Apr 17;12(8):2902. doi: 10.3390/jcm12082902. J Clin Med. 2023. PMID: 37109238 Free PMC article.

3

Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: Clarifications on fetal outcomes.

Delagrange L, Dupuis O, Dupuis-Girod S. Delagrange L, et al. BJOG. 2023 May;130(6):690-692. doi: 10.1111/1471-0528.17420. Epub 2023 Mar 5. BJOG. 2023. PMID: 36872070 No abstract available.

4

Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients.

Lesca G, Genin E, Blachier C, Olivieri C, Coulet F, Brunet G, Dupuis-Girod S, Buscarini E, Soubrier F, Calender A, Danesino C, Giraud S, Plauchu H; French-Italian HHT Network. Lesca G, et al. Eur J Hum Genet. 2008 Jun;16(6):742-9. doi: 10.1038/ejhg.2008.3. Epub 2008 Feb 20. Eur J Hum Genet. 2008. PMID: 18285823

5

Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia.

Benzinou M, Clermont FF, Letteboer TG, Kim JH, Espejel S, Harradine KA, Arbelaez J, Luu MT, Roy R, Quigley D, Higgins MN, Zaid M, Aouizerat BE, van Amstel JK, Giraud S, Dupuis-Girod S, Lesca G, Plauchu H, Hughes CC, Westermann CJ, Akhurst RJ. Benzinou M, et al. Nat Commun. 2012 Jan 10;3:616. doi: 10.1038/ncomms1633. Nat Commun. 2012. PMID: 22233626 Free PMC article.

6

Hereditary hemorrhagic telangiectasia: to transplant or not to transplant?

Dupuis-Girod S, Buscarini E. Dupuis-Girod S, et al. Liver Int. 2016 Dec;36(12):1741-1744. doi: 10.1111/liv.13210. Liver Int. 2016. PMID: 27864870

7

Response to Bevacizumab for the treatment of Rendu-Osler disease-A note of caution.

Dupuis-Girod S, Buscarini E. Dupuis-Girod S, et al. Liver Int. 2017 Jun;37(6):928. doi: 10.1111/liv.13385. Liver Int. 2017. PMID: 28544692 No abstract available.

8

The Lung in Hereditary Hemorrhagic Telangiectasia.

Dupuis-Girod S, Cottin V, Shovlin CL. Dupuis-Girod S, et al. Respiration. 2017;94(4):315-330. doi: 10.1159/000479632. Epub 2017 Aug 30. Respiration. 2017. PMID: 28850955 Free article. Review.

9

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT).

Shovlin CL, Buscarini E, Kjeldsen AD, Mager HJ, Sabba C, Droege F, Geisthoff U, Ugolini S, Dupuis-Girod S. Shovlin CL, et al. Orphanet J Rare Dis. 2018 Aug 15;13(1):136. doi: 10.1186/s13023-018-0850-2. Orphanet J Rare Dis. 2018. PMID: 30111344 Free PMC article.

10

Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination.

Shovlin C, Bamford K, Sabbà C, Mager HJ, Kjeldsen A, Droege F, Buscarini E, Dupuis-Girod S; VASCERN HHT. Shovlin C, et al. Haematologica. 2019 Feb;104(2):e85-e86. doi: 10.3324/haematol.2018.209791. Haematologica. 2019. PMID: 30705116 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters